Increased serum S100B concentration correlates with hippocampal S100B overexpression and cellular damage following chronic cerebral hypoperfusion

[1]  T. Beems,et al.  GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.

[2]  C. Freitag,et al.  Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  M. Buchfelder,et al.  Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. , 2010, Acta neurochirurgica. Supplement.

[4]  B. Norrving,et al.  Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation , 2009, Journal of Neurology.

[5]  D. Souza,et al.  Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat , 2009, Brain Research.

[6]  S. Yoshida,et al.  Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia , 2008, Brain Research.

[7]  F. Bari,et al.  Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases , 2007, Brain Research Reviews.

[8]  V. Ozacmak,et al.  AT1 Receptor Blocker Candesartan-induced Attenuation of Brain Injury of Rats Subjected to Chronic Cerebral Hypoperfusion , 2007, Neurochemical Research.

[9]  Ning Zhang,et al.  Cilostazol Protects Against Brain White Matter Damage and Cognitive Impairment in a Rat Model of Chronic Cerebral Hypoperfusion , 2006, Stroke.

[10]  P. Schestatsky,et al.  S100B and NSE serum levels in patients with Parkinson's disease. , 2005, Parkinsonism & related disorders.

[11]  L. Lindberg,et al.  Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. , 2003, British journal of anaesthesia.

[12]  M. Tuzcu,et al.  Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. , 2003, European journal of pharmacology.

[13]  I. Bogoch,et al.  Enhanced epileptogenesis in S100B knockout mice. , 2002, Brain research. Molecular brain research.

[14]  A. Eggermont,et al.  On the release and half‐life of S100B protein in the peripheral blood of melanoma patients , 2001, International journal of cancer.

[15]  E. Peskind,et al.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease , 2001, Neurochemistry International.

[16]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[17]  C. Alling,et al.  Elimination of S100B and renal function after cardiac surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.

[18]  D. Bergqvist,et al.  II. Improved dark adaptation after carotid endarterectomy , 1997, Neurology.

[19]  R. Skinner,et al.  In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis , 1996, Neurobiology of Aging.

[20]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.